Venmax Drugs and Pharmaceuticals Ltd — Important, 21-01-2026: Company Update

The company's Board has approved allotting 7,75,000 new Equity Shares to three warrant holders who exercised their conversion rights. These shares were issued at Rs. 20 each, generating Rs. 1.16 Crore from the balance exercise price. This increases the company's paid-up capital to Rs. 8.78 Crore, now totaling 87,82,930 shares. Investors should note that 64,81,000 convertible warrants still remain outstanding for future conversion.